The National Pharmaceutical Pricing Authority (NPPA) has revised the retail price of anti-rabies immunoglobulin and fixed rates for 39 drug formulations under the Drugs (Prices Control) Order. The move aims to regulate medicine prices and keep essential drugs affordable.
